Verition Fund Management LLC Cerus Corp Transaction History

Verition Fund Management LLC

  • $23.6 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.62 - $2.04 $70,823 - $89,184
43,718 New
43,718 $76,000
Q4 2023

Feb 14, 2024
BUY
$1.25 - $2.35 $50,181 - $94,340
40,145 New
40,145 $86,000
Q2 2021

Aug 16, 2021
SELL
$5.35 - $6.35 $63,162 - $74,968
-11,806 Closed
0 $0
Q1 2021

May 18, 2021
SELL
$5.68 - $7.87 $10,996 - $15,236
-1,936 Reduced 14.09%
11,806 $70,000
Q4 2020

Feb 16, 2021
BUY
$5.25 - $8.56 $72,145 - $117,631
13,742 New
13,742 $95,000

Others Institutions Holding CERS

# of Institutions
159
Shares Held
146M
Call Options Held
48.6K
Put Options Held
8.7K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $292M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email